FMP

FMP

Enter

ACHV - Achieve Life Science...

photo-url-https://financialmodelingprep.com/image-stock/ACHV.png

Achieve Life Sciences, Inc.

ACHV

NASDAQ

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

4.98 USD

0.18 (3.61%)

Valuation Date:

Oct 2, 2024 4:00 PM

Share Price on Valuation Date

$4.98

Stock Beta

1.573

Shares Outstanding

34341300

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep